[JM216, an orally active platine derivative]

Bull Cancer. 2000 Jul;87(7-8):531-6.
[Article in French]
No abstract available

MeSH terms

  • Administration, Oral
  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology*
  • Cisplatin / metabolism
  • Clinical Trials as Topic
  • DNA Adducts / metabolism
  • DNA, Neoplasm / metabolism
  • Drug Resistance, Neoplasm
  • Drug Screening Assays, Antitumor
  • Humans
  • Mice
  • Organoplatinum Compounds / administration & dosage
  • Organoplatinum Compounds / metabolism
  • Organoplatinum Compounds / pharmacology*
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • DNA Adducts
  • DNA, Neoplasm
  • Organoplatinum Compounds
  • cisplatin-DNA adduct
  • satraplatin
  • Cisplatin